Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.11 USD | +0.69% | +2.75% | -33.53% |
Sales 2024 * | 777M 1.06B | Sales 2025 * | 862M 1.18B | Capitalization | 2.01B 2.75B |
---|---|---|---|---|---|
Net income 2024 * | 192M 262M | Net income 2025 * | 225M 308M | EV / Sales 2024 * | 2.92 x |
Net Debt 2024 * | 260M 355M | Net Debt 2025 * | 41.48M 56.7M | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.68
x | Employees | 1,761 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.31% |
Latest transcript on Amphastar Pharmaceuticals, Inc.
1 day | +0.69% | ||
1 week | +2.75% | ||
Current month | -6.38% | ||
1 month | -4.86% | ||
3 months | -23.70% | ||
6 months | -8.52% | ||
Current year | -33.53% |
Managers | Title | Age | Since |
---|---|---|---|
Zi Ping Luo
FOU | Founder | 74 | 96-02-28 |
Yong Feng Zhang
CEO | Chief Executive Officer | 77 | 96-02-28 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Prins
BRD | Director/Board Member | 67 | 03-01-31 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Director/Board Member | 64 | 01-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.51% | 29 M€ | -4.33% | ||
0.37% | 45 M€ | +0.20% | ||
0.30% | 27 M€ | -5.03% | - | |
0.25% | 1,026 M€ | +6.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 41.11 | +0.69% | 263,601 |
24-04-25 | 40.83 | -0.41% | 236,143 |
24-04-24 | 41 | +0.22% | 218,270 |
24-04-23 | 40.91 | +1.84% | 210,158 |
24-04-22 | 40.17 | +0.40% | 345,090 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.53% | 2.01B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AMPH Stock